Prediagnosis Soy Food Consumption and Lung Cancer Survival in Women
- 20 April 2013
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (12) , 1548-1553
Abstract
Purpose: We recently reported an inverse association between soy food intake and lung cancer risk among nonsmoking women. The effect size for aggressive lung cancers was larger than that observed for other types of lung cancer. Therefore, we hypothesized that soy consumption may favorably affect the overall survival of patients with lung cancer. Patients and Methods: This analysis included 444 women with incident lung cancer identified from the Shanghai Women's Health Study. Prediagnosis soy food intake was assessed at enrollment and reassessed 2 years later. Proportional hazards models were used to evaluate the association between soy food intake and overall survival. Results: Of the 444 patients with lung cancer, 318 died during follow-up. Initial analyses including all patients showed that higher intake of soy food was associated with better overall survival after adjusting for demographic and lifestyle characteristics and other nonclinical factors. Larger effect sizes for the association were found after additional adjustment for tumor stage and treatment in analyses including 301 patients with data available on these clinical factors. Compared with the median intake of soy food, fully adjusted hazard ratios for total mortality associated with the 10th, 30th, 70th, and 90th percentiles of intake were 1.81 (95% CI, 1.26 to 2.59), 1.25 (95% CI, 1.09 to 1.42), 0.88 (95% CI, 0.80 to 0.97), and 0.89 (95% CI, 0.68 to 1.16), respectively. Similar inverse associations were observed for dietary isoflavone intake. Conclusion: This study suggests, to the best of our knowledge for the first time, that, among women with lung cancer, prediagnosis intake of soy food is associated with better overall survival.Keywords
This publication has 35 references indexed in Scilit:
- Lung cancer mortality risk among breast cancer patients treated with anti‐estrogensCancer, 2011
- Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialThe Lancet, 2009
- Retracted: Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell linesCancer, 2009
- Prospective cohort study of soy food intake and colorectal cancer risk in womenThe American Journal of Clinical Nutrition, 2009
- Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-B Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-B Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated MacrophagesMediators of Inflammation, 2007
- Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeysCarcinogenesis, 2006
- Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort studyBMJ, 2006
- Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung CancerJournal of Clinical Oncology, 2006
- Genistein‐induced G2‐m arrest, P21WAF1upregulation, and apoptosis in a non‐small‐cell lung cancer cell lineNutrition and Cancer, 1998
- Effect of isoflayones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F‐10 melanoma cellsNutrition and Cancer, 1998